schizophrenia
-
bipolar disorder, British Journal of General Practice, case management, comorbidities, comorbidity, Editor Laura Hemming, financial incentives, health inequalities, mortality gap, physical health, physical health inequalities, physical health monitoring, physical illness, primary care, psychosis, schizophrenia, screening, screening test, severe mental illness, systematic review, topicalPhysical health checks in SMI: case management shows most promise
People living with severe mental ill health are more likely to develop…
-
anti-obesity medicine, antipsychotics, bipolar disorder, British Journal of Psychiatry Open, Editor Simon Bradstreet, GLP-1 receptor agonists, GLP1, meta-analysis, metabolic health, mortality gap, obesity, physical health, psychosis, schizophrenia, semaglutide, systematic review, tirzepatide, weight gain, weight lossNew heavyweight contender against antipsychotic weight gain? Semaglutide enters the ring
Antipsychotics can be life-changing medications, but they often come with an unwelcome…
-
antipsychotics, biomarkers, brain metabolites, Editor Eimear Foley, first episode psychosis, glutamate, glutamatergic dysfunction, JAMA Psychiatry, mega-analysis, meta-analysis, neuroimaging, personalisation, personalised medicine, prediction, proton magnetic resonance spectroscopy, psychosis, schizophrenia, systematic review, treatment resistance, treatment responseCan brain metabolites predict who responds to antipsychotics?
Antipsychotics are the first choice of treatment for people with schizophrenia or…
-
antipsychotics, BPRS, Drugs, hypoglycemia, lithium, mood stabilizer augmentation, pancytopenia, psychopharmacology, schizophrenia, treatment-resistant schizophrenia, valproateLithium vs. Valproate in Residual Schizophrenia: Case Safety Signal
A 2026 case report described valproate 800 mg/day improving agitation in residual-phase…
-
avolition, cognitive behavioral therapy for psychosis, delusion severity, FaceYourFears trial, paranoia, psychosis, schizophrenia, schizophrenia spectrum disorders, therapy, VR-CBTVR-CBT for Paranoia May Fit High-Avolition Schizophrenia Patients
A 254-person FaceYourFears moderator analysis found that people with schizophrenia-spectrum paranoia and…
-
aggression, antipsychotics, bdnf, cognition, inflammation, left DLPFC, Neurostimulation, randomized trial, risperidone, rtms, schizophreniarTMS Plus Risperidone Improved Schizophrenia Cognition
A 2026 randomized study involving 80 people with schizophrenia found that adding…
-
antipsychotics, bipolar disorder, borderline personality disorder, clozapine, delusional disorder, depression, Editor Simon Bradstreet, Finland, hospital admission, mood stabilisers, off-label prescribing, population-based cohort study, psychosis, psychotic depression, schizophrenia, Sweden, The Lancet PsychiatryCould clozapine reduce psychiatric admissions beyond schizophrenia?
Clozapine is widely regarded as the gold standard antipsychotic for treatment-resistant schizophrenia…
-
antipsychotics, bipolar disorder, borderline personality disorder, clozapine, delusional disorder, depression, Editor Simon Bradstreet, Finland, hospital admission, mood stabilisers, off-label prescribing, population-based cohort study, psychosis, psychotic depression, schizophrenia, Sweden, The Lancet PsychiatryCould clozapine reduce psychiatric admissions beyond schizophrenia?
Clozapine is widely regarded as the gold standard antipsychotic for treatment-resistant schizophrenia…
-
antipsychotic, BMJ Mental Health, cardiovascular disease, cardiovascular events, cohort study, Denmark, Editor Eimear Foley, electronic health records, external validation, health inequalities, lasso regression, logistic regression, machine learning, mixed methods, mortality gap, physical health, physical health inequalities, prediction, psychosis, registry data, risk factors, risk prediction, schizophrenia, Sweden, topical, xgboostPredicting cardiovascular disease in schizophrenia: does machine learning actually help?
On average, people with schizophrenia spectrum disorders die 15 to 20 years…
-
antipsychotic, BMJ Mental Health, cardiovascular disease, cardiovascular events, cohort study, Denmark, Editor Eimear Foley, electronic health records, external validation, health inequalities, lasso regression, logistic regression, machine learning, mixed methods, mortality gap, physical health, physical health inequalities, prediction, psychosis, registry data, risk factors, risk prediction, schizophrenia, Sweden, topical, xgboostPredicting cardiovascular disease in schizophrenia: does machine learning actually help?
On average, people with schizophrenia spectrum disorders die 15 to 20 years…
